Retrospective analysis on the management of anticoagulants and antiplatelet agents for scheduled endoscopy

Journal of Gastroenterology

Volumn 44, Issue 12, 2009, Pages 1185-1189

  Ono, Satoshi ^a   Fujishiro, Mitsuhiro ^a   Hirano, Kousuke ^a   Niimi, Keiko ^a   Goto, Osamu ^a   Kodashima, Shinya ^a   Yamamichi, Nobutake ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anticoagulant; Antiplatelet agent; Cessation; Complication; Endoscopy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; ICOSAPENTAENOIC ACID; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PURINERGIC RECEPTOR BLOCKING AGENT; SEROTONIN ANTAGONIST; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; APPOINTMENTS AND SCHEDULES; ASPIRIN; DRUG MONITORING; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; GUIDELINES AS TOPIC; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; TICLOPIDINE; WARFARIN;

EID: 73449130126     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0127-6     Document Type: Article

References (18)

1. Antiplatelet Trialists' Collaboration 1994 Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 81 106
2. HC Diener L Cunha C Forbes J Sivenius P Smets A Lowenthal European Stroke Prevention Study. 2 1996 Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke J Neurol Sci 143 1 13 10.1016/S0022-510X(96)00308-5 1:CAS:528:DyaK2sXisFOktQ%3D%3D 8981292 (Pubitemid 26402780)
3. S Yusuf F Zhao SR Mehta S Chrolavicius G Tognoni KK Fox 2001 Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 494 502 10.1056/NEJMoa010746 1:CAS:528:DC%2BD3MXms1arsrY%3D 11519503 (Pubitemid 32758501)
4. Y Shinohara F Gotoh H Tohgi, et al. 2008 Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study Cerebrovasc Dis 26 63 70 10.1159/000135654 1:CAS:528:DC%2BD1cXnvFCis7w%3D 18511873 (Pubitemid 351931422)
5. J Weil D Colin-Jones M Langman, et al. 1995 Prophylactic aspirin and risk of peptic ulcer bleeding BMJ 310 827 830 1:STN:280:DyaK2M3islSntg%3D%3D 7711618
6. HT Sorensen L Mellemkjaer WJ Blot, et al. 2000 Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin Am J Gastroenterol 95 2218 2224 1:CAS:528:DC%2BD3cXntFCmtr8%3D 11007221
7. J Hallas M Dall A Andries, et al. 2006 Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study BMJ 333 726 10.1136/bmj.38947.697558.AE 16984924 (Pubitemid 44555169)
8. AS Taha WJ Angerson RP Knill-Jones O Blatchford 2006 Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy Aliment Pharmacol Ther 23 489 495 10.1111/j.1365-2036.2006.02784.x 1:CAS:528:DC%2BD28Xit12ju7g%3D 16441469 (Pubitemid 43382003)
9. HD Aronow SR Steinhubl DM Brennan PB Berger EJ Topol 2009 Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial Am Heart J 157 369 374 10.1016/j.ahj.2008.09.011 1:CAS:528:DC%2BD1MXhtlSkt70%3D 19185647
10. K Ogoshi E Kaneko M Tada, et al. 2005 The management of anticoagulation and antiplatelet therapy for endoscopic procedures Gastroenterol Endosc 47 2691 2695
11. GM Eisen TH Baron JA Dominitz, et al. 2002 Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures Gastrointest Endosc 55 775 779 10.1016/S0016-5107(02)70402-1 12024126
12. MJ Zuckerman WK Hirota DG Adler, et al. 2005 ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures Gastrointest Endosc 61 189 194 10.1016/S0016-5107(04) 02392-2 15729224 (Pubitemid 40261064)
13. M Fujishiro I Oda Y Yamamoto, et al. 2009 Multi-center survey regarding the management of anticoagulation and antiplatelet therapy for endoscopic procedures in Japan J Gastroenterol Hepatol 24 214 218 10.1111/j.1440-1746.2008. 05604.x 18823431
14. B Napoleon B Boneu L Maillard, et al. 2006 Guidelines of the French society for digestive endoscopy (SFED) Endoscopy 38 632 638 10.1055/s-2006- 925086 1:STN:280:DC%2BD28vivVejtw%3D%3D 16586249 (Pubitemid 43978536)
15. Japanese Circulation Society 2004 Guidelines for management of anticoagulant and antiplatelet therapy in cardiovascular disease (JCS 2004) (in Japanese) Circ J 68 1153 1219
16. T Komatsu Y Tamai H Takami K Yamagata S Fukuda A Munakata 2005 Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures J Gastroenterol 40 698 707 10.1007/s00535-005-1613-0 1:CAS:528:DC%2BD2MXntVehsb4%3D 16082586 (Pubitemid 41349081)
17. SY Lee SJ Tang DC Rockey, et al. 2008 Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the east and the west Gastrointest Endosc 67 1076 1081 10.1016/j.gie.2007.11.037 18384789
18. K Ido K Togashi H Yamamoto K Satoh 2004 How antiplatelets and anticoagulants should be managed in endoscopic treatment Gastroenterol Endosc 46 2079 2085 (in Japanese with English abstract)